units

PAC4441

Faculty of Pharmacy and Pharmaceutical Sciences

18 September 2017 25 November 2024

print version

This unit entry is for students who completed this unit in 2016 only. For students planning to study the unit, please refer to the unit indexes in the the current edition of the Handbook. If you have any queries contact the managing faculty for your course or area of study.

Monash University

6 points, SCA Band 2, 0.125 EFTSL

Undergraduate - Unit

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered.

Faculty

Pharmacy and Pharmaceutical Sciences

Coordinator(s)

Dr Betty Exintaris (Parkville); Dr Nafees Ahemad (Malaysia)

Offered

Malaysia

  • First semester 2016 (Day)

Parkville

  • First semester 2016 (Day)

Synopsis

This unit will provide an understanding of the pathophysiology, pharmacotherapy and management of various endocrine conditions and renal disease. Specifically, the unit will cover the hypothalamic-pituitary-adrenal (HPA) axis, thyroid, parathyroid and adrenocortical dysfunction, diabetes, men's and women's health and acute, chronic and drug-induced renal disease. Students will perform a number of tasks which will foster the development of critical thinking and oral and written communication skills.
Drug therapy principles for the aforementioned conditions and patient groups will be emphasised enabling students to acquire the skills necessary to provide clinical pharmacy services within these areas.

Outcomes

This unit aims to provide the foundations for understanding the main endocrine (hormone) systems in man, diseases of the endocrine system and pharmacotherapies that act through these systems. It will

also provide the basic knowledge required for the diagnosis and management of patients with renal disease.

  • The chemistry, pharmacology and clinical aspects of medications associated with each area will be presented in detail in an integrated fashion
  • The signs and symptoms associated with these conditions
  • The chemistry of the different classes of drugs used in the management of these disorders
  • The concepts of structure-activity relationships for the drugs used in the management of these disorders
  • The pharmacology of the drugs used in the management of these disorders.
  • The signs and symptoms, emphasising cardinal symptoms, of many conditions associated with these areas
  • The management of thyroid disease, diabetes and men's and women's health issues including drug and non-drug therapies
  • Management of renal disease including drug and non-drug therapies
  • Current best practice for the management of these conditions with emphasis on the role of the pharmacist
  • Individual differences which may occur in these disorders and how they can be managed.

Assessment

Quizzes (4X5%) 20%; Debates 10%; Tutorials (X2)10%; Final exam 60%

Workload requirements

72 hours of formal study per semester (36 hours of lectures, 4 hours of tutorials, 2 hours of debates, 2 hours of quizzes and 28 hours of self-directed learning).

See also Unit timetable information

Chief examiner(s)

Dr Betty Exintaris (Parkville); Mr David Chong (Malaysia)

Additional information on this unit is available from the faculty at:

http://www.monash.edu/pharm/current/